Koji Ishida

Director/Board Member at Sumitomo Pharma America, Inc.

76 year

Health Technology

Distribution Services

Government

Profile

Koji Ishida is currently a Director at Sumitomo Pharma America, Inc. He previously worked as a Director at Bank of Japan from 2011 to 2016 and as an Independent Outside Director at Sumitomo Corp.
Mr. Ishida completed his undergraduate degree at the Graduate School of Economics University of Tokyo in 1970.

Koji Ishida active positions

Companies	Position	Start
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Director/Board Member	-

All active positions of Koji Ishida

Former positions of Koji Ishida

Companies	Position	End
BANK OF JAPAN	Director/Board Member	2016-06-28
SUMITOMO CORPORATION	Director/Board Member	-

See the detail of Koji Ishida's experience

Training of Koji Ishida

Graduate School of Economics University of Tokyo

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Koji Ishida's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SUMITOMO CORPORATION	Distribution Services
BANK OF JAPAN	Government

Private companies	1
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Health Technology